Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFECTS trial of fluoxetine after acute stroke
ISRCTN13020412Phase 3Completed
- Sponsor
- Karolinska Institutet
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke and intraparenchymal hematoma (IPH) comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Modified Rankin Scale at 6 months. Started Oct 2014; status: completed.
02
Drugs
fluoxetine
03
Conditions
ischemic strokeintraparenchymal hematoma (IPH)
Beyond the preview
Go deeper on ISRCTN13020412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13020412.